Key facts
- This page summarizes John Simard's Form 4 filing for XBiotech Inc. (XBIT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2026, 15:49.
John Simard - 03 Nov 2026 Form 4 Insider Report for XBiotech Inc. (XBIT)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- XBIT
- Reported as of
- 03 Nov 2026
- Net transaction value
- +$143,409
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2026, 15:49:10 UTC
- Prior SEC filing
- 28 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- John Simard
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
John Simard filed Form 4 for XBiotech Inc. (XBIT) on 13 Nov 2026.
Change
- Previous filing in this sequence was filed on 28 Oct 2026.
- Current net transaction value: +$143,409.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001639078
Primary reporting owner
SIMARD JOHN
- Relationship
- Director, 10%+ Owner
- Address
- 5217 WINNEBAGO LANE, AUSTIN
- Signature
- John Simard
- Signature date
- 13 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XBIT
transaction
Common Stock
Purchase
- Transaction value
- $143,409
- Shares
- +70,000
- Change %
- +1.7%
- Price
- $2.05
- Shares after
- 4,261,690
- Date
- 03 Nov 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.